Clinical Trial Update: A Non-Randomized Study of the NightHawk Peripheral Plaque Excision System During Plaque Excision of Peripheral Arterial Disease [Phase 2]

View source ↗

Summary

This document reports a terminated, non-randomized Phase 2 trial evaluating the NightHawk Peripheral Plaque Excision System for peripheral artery disease. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• NightHawk Peripheral Plaque Excision System

Snippet

Sponsor: FoxHollow Technologies | Conditions: Peripheral Vascular Diseases | Phase 2 | Status: TERMINATED